Clinical trials recruiting for Refractory Lung Adenocarcinoma
Fewer than 3 recruiting trials found.
2
Recruiting trials
2
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Avutometinib | 1 |
| Defactinib | 1 |
| Devimistat | 1 |
| Fluorouracil | 1 |
| Gemcitabine Hydrochloride | 1 |
| Hydroxychloroquine | 1 |
| Nivolumab | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Georgia | 1 |
| Illinois | 1 |
Top cities
Self-screener
Recruiting trials
- CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
- Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer
Related conditions
Trials recruiting for Refractory Lung Adenocarcinoma often also study these conditions. Each links to its own recruiting-trial list.
Stage IV Lung Cancer AJCC v8 45Stage III Lung Cancer AJCC v8 22Lung cancer 2180Stage IV Pancreatic Cancer AJCC v8 19Stage IV Ovarian Cancer AJCC v8 4Stage IV Colorectal Cancer AJCC v8 21Stage III Pancreatic Cancer AJCC v8 14Stage III Ovarian Cancer AJCC v8 3Stage III Colorectal Cancer AJCC v8 10Stage II Pancreatic Cancer AJCC v8 9
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Refractory Lung Adenocarcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.